Scenesse® (afamelanotide) – New orphan drug approval
October 8, 2019 - The FDA announced the approval of Clinuvel’s Scenesse (afamelanotide), to increase pain free light exposure in adult patients with a history of phototoxic reactions from erythropoietic protoporphyria (EPP).
Download PDF
